Cardiovascular diseases and future risk of hip fracture in women

Osteoporosis International

Volumn 18, Issue 10, 2007, Pages 1355-1362

  Sennerby, U ^a   Farahmand, B ^b,c   Ahlbom, A ^b   Ljunghall, S ^c   Michaelsson K ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

Cardiovasculare disease; Cerebrovascular laesion; Heart failure; Hip fracture; Hypertension; Osteoporosis

Indexed keywords

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART FAILURE; HIP FRACTURE; HIP RADIOGRAPHY; HOSPITALIZATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SWEDEN;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HIP FRACTURES; HUMANS; MIDDLE AGED; ODDS RATIO; OSTEOPOROSIS; RISK FACTORS; SWEDEN;

EID: 34548564710     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-007-0386-0     Document Type: Article

References (44)

1. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA (1999) Mortality after all major types of osteoporotic fracture in and women: an observational study. Lancet 353:878-882
2. Johnell O, Kanis JA, Oden A, Sernbo I, Redlund-Johnell I, Petterson C, De Laet C, Jonsson B (2004) Mortality after osteoporotic fractures. Osteoporosis Int 15:38-42
3. Farahmand BY, Michaelsson K, Ahlbom A, Ljunghall S, Baron JA (2005) Survival after hip fracture. Osteoporosis Int 16:1583-1590
4. Pennisi P, Signorelli SS, Riccobene S, Celotta G, Di Pino L, La Malfa T, Fiore CE (2004) Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporosis Int 15:389-395
5. Kiel DP, Kauppila LI, Cupples LA, Hannan MT, O'Donnell CJ, Wilson PW (2001) Bone loss and the progression of abdominal aortic calcification of 25-year period: The Framingham Heart Study. Calcif Tissue Int 68:271-276
6. von der Recke P, Hansen MA, Hassager C (1999) The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 106:273-278
7. Marcovitz PA, Tran HH, Franklin BA, O'Neill WW, Yerkey M, Boura J, Kleerkoper M, Dickinson CZ (2005) Usefulness of bone mineral density to predict significant coronary artery disease. Am J Cardiol 96:1059-1063
8. Collin-Osdoby P (2004) Regulation of vascular calcification by osteoclast regulatory factors RANK-L and osteoprotegerin. Circ Res 95:1046-1057
9. Ikeda F, Nishimura R, Matsubara T, Tanaka S, Inoue J, Reddy SV, Hata K, Yamashita K, Hiraga T, Watanabe T, Kukita T, Yoshioka K, Rao A, Yoneda T (2004) Critical roles of c-Jun signaling in regulation of NFAT family and RANK-L regulated osteoclast differentiation. J Clin Inv 114(4):475-484
10. Suda T, Takahashi N, Martin TJ (1992) Modulation of osteoclast differentiation. Endocr Rev 13:66-80
11. Kwan Tat S, Padrines M, Theoleyre S, Heyman D, Fortun Y (2004) IL-6, RANK TNF-alpha/IL-1: interrelation in bone resorption. Cytokine Growth Factor Rev 15:49-60
12. Theill LE, Boyle WJ, Penninger JM (2002) RANK-L and RANK: T cells, bone loss and mammalian evolution. Annu Rev Immunol 20:795-823
13. Cappucio FP, Meilahn E, Zmuda JM, Cauley JA (1999) High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group. Lancet 18:354(9183):971-975
14. Johnell O, Kanis JA, Oden A, Johansson H, DeLaet C, Delmas P, Eisman JA, Fujuwara S, Kroger H, Mellström D, Meunier PJ, Melton LJ 3rd, O'Neill T, Pols H, Reeve J, Silman A, Tenenhouse (2005) Predictive value of BMD for hip and other fractures. J Bone Miner Res 20(7):1185-1194
15. Mussolino ME, Madans JH, Gillum RF (2003) Bone mineral density and mortality in women and men: the NHANES I epidemiologic follow-up study. Ann Epidemiol 13(10):692-697, Nov
16. Michaelsson K, Baron JA, Farahmand BY, Persson I, Ljunghall S (1999) Oral-contraceptive use and risk of hip fracture:a case control study. Lancet 1;353(9163):1481-1484
17. Michaelsson K, Baron J, Farahmand BY, Johnell O, Magnusson C, Persson PG, Persson I, Ljunghall S (1998) Hormone replacement therapy and risk of hip fracture: population based case-control study. The Hip Fracture Study Group. BMJ 20;316(7148):1858-1863
18. Bagger YZ, Tanko LB, Alexandersen P, Qin G, Christiansen C; Prospective Epidemiological Risk Factors Study Group (2006) Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hip. J Intern Med 259:598-605
19. Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V (2004) Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab 89:4246-4253
20. Tanko LB, Christiansen C, Cox DA, Geiger MJ, McNabb MA, Cummings SR (2005) Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 20:1912-1920
21. Mc Farlane SI, Muniyappa R, Shin JJ, Bahtiyar G, Sowers JR (2004) Review; Osteoporosis and cardiovascular disease. Brittle Bones and Boned Arteries. Is there a link? Endocrine 23(1):1-10
22. Bevilacqua M, Dominguez LJ, Rosini S, Bargallo M (2005) Bisphonates and atherosclerosis: why? Lupus 14(9):773-779
23. Power ML, Heaney RP, Kalkwarf HJ, Pitkin RM, Repke JT, Tsang RC, Schulkin J (1999) The role of calcium in health and disease. Am J Obstret Gynecol 181(6):1560-1569
24. Zitterman A, Schleithoff SS, Koerfer R (2005) Putting cardiovascular disease and vitamin D insufficiency into perspective. Am J Obstet Gynecol 94(4):483-492
25. Fujita T (1985) Aging and calcium as an environmental factor. J Nutr Sci Vitaminol Suppl:S15-S19
26. Mc Farlane SI, Muniyappa R, Shin JJ, Bahtiyar G, Sowers JR (2004) Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link. Endocrine 23(1):1-10
27. Baldini V, Mastropasqua M, Francucci CM, D'Erasmo E (2005) Cardiovascular disease and osteoporosis. J Endocrinol Invest 28(10 Suppl):69-72
28. Browner WS, Lui LY, Cummings SR (2001) Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women. J Clin Endocrinol Metab 86:631-637
29. Tsutsui T, Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Ohnishi M, Kinoshita M (2002) Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic heart failure. J Am Coll Cardiol 20;39(6):957-962
30. Frostegard J, Wu R, Lemne C, Thulin T, Witzum JL, de Faire U (2003) Circulating oxidized low-density lipoprotein is increased in hypertension. Clin Sci (Lond) 105(5):815-820
31. Koh JM, Young-Sun L, Yang Son K, Duk Jae K, Hong-Hee K, Joong-Yeol P, Ki-Up L, Ghi Su K (2006) Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res 21(7):1003-1011
32. McLean RR, Jacues PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, Hannan MT, Cupples LA, Kiel DP (2004) Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 13;350(20):2042-2049
33. van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, de Jonge R, Lindemans J, de Groot LC, Hofman A, Witteman JC, van Leeuwen JP, Breteler MM, Lips P, Pols HA, Uitterlinden AG (2004) Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 13;350(20):2033-2041
34. Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K (2005) Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA 2;293(9):1082-1088
35. Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, Sawyer DB, Levy D, Wilson PW, D'Agostini RB (2003) Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction; Framingham Heart Study. Circulation 107:1486-1491
36. Rodrigo R, Passalacqua W, Araya J, Orellana M, Rivera G (2003) Homocysteine and essential hypertension. J Clin Pharmacol 43(12):1299-1306
37. Douchi T, Yamamoto S, Oki T et al (2000) Difference in the effect of adiposity on bone density between pre- and postmenopausal women. Maturitas 34:261-266
38. Kontogianni MD, Dafni UG, Routsias JG, Skopouli FN (2004) Blood leptin and adiponectin as possible mediators of relation between fat mass and BMD in perimenopausal women. J Bone Miner Res 19:546-551
39. Lechnik L, Register TC, Hsu FC et al (2003) Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 33:646-651
40. Rajala MW, Scherer PE (2003) Mini-review: the adipocyte-at the crossroads of energy homeostasis, inflammation and atherosclerosis. Endocrinology 144:3765-3773
41. Kershaw EE, Flier JS (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548-2556
42. Melton LJ 3rd, Brown RD Jr, Achenbach SJ, O'Fallon WM, Whisnant JP (2001) Long-Term fracture risk following ischemic stroke: a population-based study. Osteoporos Int 12:980-986
43. Lindblad U, Ranstam L, Ranstam J, Peterson M (1993) Validity of register data on myocardial infarction and acute stroke: the Skaraborg Hypertension Project. Scand J Soc Med 21:3-9
44. Ingelsson E, Ärnlöv J, Sundström J, Lind L (2005) The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail 7:787-791